Applicability of Plant Extracts in Preclinical Studies of Melanoma: A Systematic Review

Abstract

Melanoma is the most aggressive form of skin cancer and arises from melanocyte gene mutation. This disease is multifactorial, but its main cause is the excessive exposure to ultraviolet radiation. Currently, available chemotherapy has shown little expressive results, which may justify the high use of natural products to treat this cancer. We performed a systematic review to compile the results of studies carried out in murine models and investigated the effect of plant extracts on melanoma treatment. Papers were selected in MEDLINE/Pubmed and Scopus according to the PRISM statement. Search filters were developed using three parameters: plant extract, melanoma, and animal model. The 35 identified studies were all submitted to the criteria described in the ARRIVE guidelines. The different extracts showed antiangiogenic, antimetastatic, antioxidant, and anti-inflammatory activity, and also proved to be effective in cell cycle modulation and apoptosis evasion. Bias analysis evidenced the absence of standardized experimental designs, as well as failures in statistical tests and in the presentation of results. The analysis of the studies suggests that the use of plant extracts is effective for the treatment of melanoma in murine models.

Clinical outcomes of BRAF plus MEK inhibition in melanoma: A meta‐analysis and systematic review

“…The selection criterions were: (1) The study design of literature was randomized controlled trial. (2) Patients in the study were diagnosed with metastatic melanoma.…”

“…Melanoma is a severe cutaneous carcinoma with an increasing incidence rate . Melanoma accounts for only 2.3% of all cutaneous malignancies, but it leads to the majority of skin‐cancer deaths .…”

“…Melanoma is a severe cutaneous carcinoma with an increasing incidence rate. [1][2][3] Melanoma accounts for only 2.3% of all cutaneous malignancies, but it leads to the majority of skincancer deaths. 4,5 The 5-year survival rate of patients with metastatic melanoma is between 5% and 19%.…”

Kinesin family member 18B: A contributor and facilitator in the proliferation and metastasis of cutaneous melanoma

“…Malignant melanoma is the most aggressive type of cutaneous tumor with dramatic growth in its incidence globally . Malignant melanoma is regarded as a multifactorial disease, with excessive ultraviolet radiation, which might result in genetic mutations and DNA damage as the leading risk factor . It has been reported that melanoma is the result of multiple and progressive DNA damage .…”

“…Malignant melanoma is regarded as a multifactorial disease, with excessive ultraviolet radiation, which might result in genetic mutations and DNA damage as the leading risk factor . It has been reported that melanoma is the result of multiple and progressive DNA damage . Of note, melanoma is resistant to almost all available treatment and becomes incorrigible, once it develops visceral organs and distant site metastasis .…”